Skip to main navigation Skip to search Skip to main content

Upregulated level of TRAIL and soluble Fas ligand in IFN-beta treated relapsing-remitting multiple sclerosis patients

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Scientific

Original languageEnglish
Title of host publication23rd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS)
Publication statusPublished - 2007
Publication typeB3 Article in conference proceedings

Cite this